Literature DB >> 8134344

Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

S W Lowe1, T Jacks, D E Housman, H E Ruley.   

Abstract

p53-deficient mouse embryonic fibroblasts were used to establish a direct mechanism of tumor suppression by p53 involving the destruction of oncogene-expressing cells by apoptosis. The absence of p53 enhanced cell growth, appeared sufficient for immortalization, and allowed a single oncogene [adenovirus early region 1A (E1A)] to transform cells to a tumorigenic state. p53 suppressed transformation of E1A-expressing cells by apoptosis. Apoptosis was associated with p53 stabilization and was triggered by environmental signals that normally suppress cell growth. Absence of even a single p53 allele significantly enhanced cell growth and survival. Although abrogation of apoptosis allowed transformation by E1A alone, escape from apoptosis susceptibility was not a prerequisite for tumor growth. Consequently, p53 mutation could enhance the survival of malignant cells expressing oncogenes activated early in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134344      PMCID: PMC43302          DOI: 10.1073/pnas.91.6.2026

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Transforming collaborations between ras and nuclear oncogenes.

Authors:  H E Ruley
Journal:  Cancer Cells       Date:  1990 Aug-Sep

2.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

Authors:  P Hinds; C Finlay; A J Levine
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 3.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

4.  Role of the adenovirus early region 1B tumor antigens in transformation and lytic infection.

Authors:  R Bernards; M G de Leeuw; A Houweling; A J van der Eb
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

5.  In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.

Authors:  B R Franza; K Maruyama; J I Garrels; H E Ruley
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

6.  Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells.

Authors:  K Blochlinger; H Diggelmann
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

7.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

8.  The biology of cell death in tumours.

Authors:  A H Wyllie
Journal:  Anticancer Res       Date:  1985 Jan-Feb       Impact factor: 2.480

9.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

Authors:  S W Lowe; H E Ruley; T Jacks; D E Housman
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

10.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

View more
  85 in total

1.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

3.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Suppression of tumorigenesis by the p53 target PUMA.

Authors:  Michael T Hemann; Jack T Zilfou; Zhen Zhao; Darren J Burgess; Gregory J Hannon; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

5.  Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins.

Authors:  A V Samuelson; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

6.  Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways.

Authors:  Anshu M Roy; Manjeshwar S Baliga; Craig A Elmets; Santosh K Katiyar
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

7.  A unique role of the DNA fragmentation factor in maintaining genomic stability.

Authors:  Bin Yan; Huili Wang; Yuanlin Peng; Ye Hu; He Wang; Xiuwu Zhang; Qi Chen; Joel S Bedford; Mark W Dewhirst; Chuan-Yuan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

8.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

9.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 10.  Lessons from the p53 mutant mouse.

Authors:  T Jacks
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.